85-5864-63　Regorafenib (Pyridine)-N-oxide 100mg　CAS No:835621-11-9　464563

特徴

• Regorafenib (Pyridine)-N-oxide is a synthetic metabolite of Regorafenib and is used for treatment and prevention of cancer. Regorafenib is a multi-target inhibitor for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1 with IC50s of 13/4.2/46, 22, 7, 1.5 and 2.5nM, respectively.
• Synonyms:4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide 1-Oxide
• Molecular Formula:C₂₁H₁₅ClF₄N₄O₄
• Molecular Weight:498.81
• Appearance:White to off-white solid
• Purity:As reported
• Melting Point:223-227°C
• Solubility:DMSO (Slightly), Methanol (Slightly, Heated)
• Storage and Stability:Store at 4°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.

仕様

• Size：100mg
• Grade：Highly Purified
• Purity：As reported
• Form：White to off-white solid
• Molecular Formula：C₂₁H₁₅ClF₄N₄O₄
• Molecular Weight Non Ab：498.81
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
• CAS No ：835621-11-9

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]